Chicago Neuroscience Institute News

---

 Dr. Durrant and Staff Visit the Shirley Ryan Ability Lab in Chicago Dr. David Durrant, Director of the Chicago Neuroscience Institute (CNI) and Alyssa a staff member the  Institute recently spent the day at the Shirley Ryan Ability Lab, formerly the Rehabilitation Institute of   Chicago (RIC). This included a supervised tour through innovation centers and specialty labs. CNI refers   some of its complex patients to the Shirley Ryan Ability Lab for intense or specialized neurorehabilitation. The facility offers both inpatient and outpatient care and attracts patients from all  over the world. Dr. Durrant set up the integrated tour to learn more about their current capabilities  including their approach to human performance evaluation and enhancement. Alyssa was interested in their pediatric programs, as she considers a career in the field of bioengineering and bionics as a   profession. Alyssa is currently a high school student and a part-time retinal imaging technologist at the   Institute.  The Shirley Ryan Ability Lab has been ranked the #1 rehabilitation facility in the country by U.S. News  & World Report since 1991. It is the only hospital of any kind to ever achieve this distinction. The Shirley  Ryan Ability Lab, like CNI, has a committed and passionate staff dedicated to excellence in neurologic   and rehabilitative care. The facility acknowledges its contribution to healthcare with its statement “we set   the standard of care in the post-acute market through our innovative applied research and discovery   programs, particularly in the areas of neuroscience, pain medicine, musculoskeletal medicine and   technology transfer”. CNI is proud to have a referral relationship with the Shirley Ryan Ability Lab. 

The Chicago Neuroscience Institute (CNI) implemented state-of-the art retinal imaging technology from  

Topcon to screen for diabetic retinal pathology and to further neurological assessment in some cases.  

CNI forwards the digital images through a telemedicine portal to a renowned ophthalmologist/retinal  

specialist for interpretation. Dr. Durrant is working with a company referred to as IDX to set up a tele- 

ophthalmology portal to access their artificial intelligence (AI) solution capable of interpreting the digital  

retinal images paralleling interpretation from the retinal specialist.  According to the company “IDX-DR is  

the first ever autonomous AI system cleared by the FDA to provide diagnostic decisions”. The  

autonomous application of AI can instantaneously detect retinal disease.